A detailed history of Jefferies Group LLC transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, Jefferies Group LLC holds 21,250 shares of COLL stock, worth $628,575. This represents 0.0% of its overall portfolio holdings.

Number of Shares
21,250
Holding current value
$628,575
% of portfolio
0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Sep 21, 2023

SELL
$15.46 - $20.1 $2.16 Million - $2.81 Million
-139,635 Reduced 86.79%
21,250 $340,000
Q3 2022

Nov 14, 2022

BUY
$15.46 - $20.1 $136,620 - $177,623
8,837 Added 71.19%
21,250 $340,000
Q2 2022

Aug 15, 2022

BUY
$14.22 - $20.88 $176,512 - $259,183
12,413 New
12,413 $26,000
Q1 2022

May 16, 2022

SELL
$17.2 - $22.5 $2.77 Million - $3.62 Million
-160,885 Closed
0 $0
Q4 2021

Sep 21, 2023

BUY
$17.5 - $21.35 $2.7 Million - $3.3 Million
154,385 Added 2375.15%
160,885 $3.01 Million
Q4 2021

Feb 14, 2022

BUY
$17.5 - $21.35 $2.82 Million - $3.43 Million
160,885 New
160,885 $3.01 Million
Q2 2021

Aug 16, 2021

SELL
$21.74 - $25.28 $141,310 - $164,320
-6,500 Closed
0 $0
Q1 2021

Sep 21, 2023

BUY
$19.25 - $26.1 $75,594 - $102,494
3,927 Added 152.62%
6,500 $154,000
Q1 2021

May 14, 2021

BUY
$19.25 - $26.1 $75,594 - $102,494
3,927 Added 152.62%
6,500 $154,000
Q4 2020

Sep 21, 2023

SELL
$17.83 - $22.29 $333,010 - $416,310
-18,677 Reduced 87.89%
2,573 $51,000
Q4 2020

Feb 16, 2021

BUY
$17.83 - $22.29 $45,876 - $57,352
2,573 New
2,573 $52,000
Q4 2018

Feb 14, 2019

SELL
$14.78 - $19.68 $272,025 - $362,210
-18,405 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$14.16 - $24.3 $260,614 - $447,241
18,405 New
18,405 $271,000
Q2 2018

Aug 14, 2018

SELL
$21.79 - $28.29 $198,289 - $257,439
-9,100 Closed
0 $0
Q1 2018

May 15, 2018

SELL
$18.15 - $29.21 $713,295 - $1.15 Million
-39,300 Reduced 81.2%
9,100 $233,000
Q4 2017

Feb 14, 2018

BUY
$9.3 - $19.14 $450,120 - $926,376
48,400
48,400 $893,000

Others Institutions Holding COLL

About COLLEGIUM PHARMACEUTICAL, INC


  • Ticker COLL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 34,126,200
  • Market Cap $1.01B
  • Description
  • Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...
More about COLL
Track This Portfolio

Track Jefferies Group LLC Portfolio

Follow Jefferies Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Group LLC with notifications on news.